Back
iShares iBonds Dec 2026 Term Corporate ETF Vs. Janux Therapeutics Industry Stock Comparison
Buy
64
IBDR
iShares iBonds Dec 2026 Term Corporate ETF
Last Price:
$24.08
Seasonality Move:
-1.49%
Sell
23
JANX
Janux Therapeutics
Last Price:
$50.53
Seasonality Move:
80.32%
Buy
64
iShares iBonds Dec 2026 Term Corporate ETF (IBDR)
is a Buy
Is iShares iBonds Dec 2026 Term Corporate ETF a Buy, Sell or Hold?
-
The current iShares iBonds Dec 2026 Term Corporate ETF [IBDR] share price is $24.07. The Score for IBDR is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
IBDR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
23
Janux Therapeutics (JANX)
is a Sell
Is Janux Therapeutics a Buy, Sell or Hold?
-
The current Janux Therapeutics [JANX] share price is $50.82. The Score for JANX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
-
JANX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IBDR Stock Price Chart
What is iShares iBonds Dec 2026 Term Corporate ETF's stock price today?
-
The iShares iBonds Dec 2026 Term Corporate ETF share price today is $24.07The current trend is relatively stagnant and IBDR is experiencing slight selling pressure.
JANX Stock Price Chart
What is Janux Therapeutics's stock price today?
-
The Janux Therapeutics share price today is $50.82Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JANX is experiencing selling pressure, which indicates risk of future bearish movement.
IBDR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 50.16 | Buy |
Chaikin Money Flow: | -544938 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (24.03 - 24.11) | Sell |
Bollinger Bands (100): | (24.07 - 24.21) | Sell |
JANX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.52 | Sell |
Relative Strength Index (14 RSI): | 41.88 | Sell |
Chaikin Money Flow: | -1994706 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (53.74 - 62.68) | Sell |
Bollinger Bands (100): | (44.76 - 56.7) | Buy |
IBDR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 24.06 | Buy |
20-day SMA: | 24.07 | Buy |
50-day SMA: | 24.08 | Sell |
200-day SMA: | 23.98 | Buy |
8-day EMA: | 24.06 | Buy |
20-day EMA: | 24.07 | Buy |
50-day EMA: | 24.09 | Sell |
200-day EMA: | 24 | Buy |
JANX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 53.68 | Sell |
20-day SMA: | 56.78 | Sell |
50-day SMA: | 54.64 | Sell |
200-day SMA: | 47.7 | Buy |
8-day EMA: | 54.12 | Sell |
20-day EMA: | 55.17 | Sell |
50-day EMA: | 54.12 | Sell |
200-day EMA: | 45.19 | Buy |
iShares iBonds Dec 2026 Term Corporate ETF Earnings Growth & IBDR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Janux Therapeutics Earnings Growth & JANX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.92 per share, and a decrease next year of $0.75 per share.
iShares iBonds Dec 2026 Term Corporate ETF Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Janux Therapeutics Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |